Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/6958caf9-648c-800e-9920-bac13abca047
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== 1) 先把「WHO 平台類似情況」的母集合講清楚:C-TAP 上到底有哪些疫苗/技術? ==== WHO 的 C-TAP 官方頁面導覽列得出來:Medigen(高端)、CSIC(西班牙公研機構)、美國 NIH、智利大學等案子(多數其實不是「商業大廠成品疫苗」)。世界衛生組織<ref>{{cite web|title=世界衛生組織|url=https://www.who.int/initiatives/covid-19-technology-access-pool|publisher=who.int|access-date=2026-01-04}}</ref> 而 Medigen 的頁面寫得非常白:2023/07 簽授權、透明、全球、非專屬,並強調它是「first … developed by a private company」進 C-TAP。世界衛生組織<ref>{{cite web|title=世界衛生組織|url=https://www.who.int/initiatives/covid-19-technology-access-pool/medigen-license-to-c-tap|publisher=who.int|access-date=2026-01-04}}</ref> 這句話本身就暗示:大部分“知名大廠疫苗”沒有走 C-TAP。
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)